Manufactured by: Ibn Sina Pharmaceutical Ind. Ltd.
Tacrolimus 0.1%, 0.03% Topical Similar medicine
Se debe tener precaución al utilizar la pomada de tacrolimus para tratar a pacientes con dermatitis atópica que probablemente sufran infecciones de la piel. No se ha demostrado la seguridad de la pomada de tacrolimus en personas con enrojecimiento generalizado de la piel (eritrodermia generalizada).
Tacrolimus puede ser más dañino para los riñones si se toma con otros medicamentos como ciclosporina, aminoglucósidos, anfotericina B, cisplatino, AINE, vancomicina, cotrimoxazol, aciclovir o ganciclovir. También existe un mayor riesgo de niveles altos de potasio cuando se usa con diuréticos ahorradores de potasio. Algunos medicamentos, como los antimicóticos azólicos, los bloqueadores de los canales de calcio, la cimetidina, el danazol, los inhibidores de la proteasa del VIH, los antibióticos macrólidos y la metoclopramida, aumentan los niveles de tacrolimus en la sangre, lo que puede aumentar los efectos secundarios. Por otro lado, fármacos como los antiácidos, la rifampicina, la rifabutina, la caspofungina, la fenitoína, el fenobarbital y la carbamazepina pueden reducir los niveles de tacrolimus, haciéndolo menos eficaz. Tomar sirolimus y tacrolimus juntos puede reducir los niveles de ambos fármacos.
La pomada de tacrolimus no debe ser utilizada por personas alérgicas al tacrolimus o a cualquier otro ingrediente de la pomada.
El tacrolimus actúa impidiendo que los linfocitos T (un tipo de célula inmunitaria) se activen, aunque su método exacto no se comprende completamente. Se adhiere a ciertas proteínas dentro de las células llamadas inmunofilinas, como la proteína de unión a FK-12 (FKBP-12). Esta conexión crea complejos que bloquean la creación de proteínas de señalización (citocinas) a través de una vía llamada calcineurina. Al bloquear la calcineurina, el tacrolimus impide que las células T se activen prematuramente, lo que conduce a una reducción de la actividad inmunitaria (inmunosupresión).
Aplique una fina capa de pomada de Tacrolim en las áreas de la piel afectadas dos veces al día y frote suave y completamente. El tratamiento debe continuar durante una semana después de la desaparición de los signos y síntomas de la dermatitis atópica. No se ha evaluado la seguridad de la pomada de Tacrolim bajo oclusión, que puede promover la exposición sistémica. La pomada de tacrolim no debe usarse con apósitos oclusivos.
Aunque los estudios de reproducción en animales han demostrado un efecto adverso en el feto y no existen estudios adecuados y bien controlados en mujeres embarazadas, durante el embarazo este medicamento se puede utilizar sólo cuando sea definitivamente necesario a pesar de los riesgos potenciales.
Las madres con un bebé recién nacido que han usado este medicamento durante los últimos 3 meses de embarazo rara vez presentan síntomas que incluyen somnolencia, rigidez o temblores musculares, problemas para alimentarse o respirar, y llanto constante. Si nota alguno de estos síntomas en su bebé, especialmente durante el primer mes, informe al médico de inmediato.
Este medicamento pasa a la leche materna. Hable con su médico antes de amamantar.
5gm tube/10gm tube Price : ৳80/150
Manufactured by: Square Pharmaceuticals Ltd.
Manufactured by: Unimed & Unihealth Manufacturers Ltd.
Manufactured by: Ibn Sina Pharmaceutical Ind. Ltd.
Manufactured by: Beximco Pharmaceuticals Ltd.
Manufactured by: Acme Laboratories Ltd.
Manufactured by: Unimed & Unihealth Manufacturers Ltd.
Click here to see 1 more similar medicines
There are few similar medicines of Dermus are manufactured by other companies using the same ingredients. Although, it would be good if you are able to use the same medicine, which has been prescribed by your Doctor. Due to availability in the local market, you can try others. Please make sure and contact your Doctor first about alternatives.
Doxepin 5% Topical is indicated for Pruritus, Chronic idiopathic urticaria (hives), Atopic dermatitis, lichen simplex chronicus
List of medicines using Doxepin 5% Topical
Hydrocortisone is indicated for Corticosteroid-responsive dermatoses, hypersensitivity reactions such as angioedema, status asthmaticus, Soft tissue inflammation, Joint inflammations, Primary or secondary adrenocortical insufficiency, Acute adrenocortical insufficiency, Shock unresponsive to conventional therapy, Congenital adrenal hyperplasia, Hypercalcemia associated with cancer, Nonsuppurative thyroiditis, Rheumatic Disorders, Dermatologic Diseases (Allergic States, Severe seborrheic dermatitis, Severe psoriasis, Pemphigus, Severe erythema multiforme), Control of severe or incapacitating allergic conditions (Bronchial asthma, Contact dermatitis, Atopic dermatitis, Serum sickness, Seasonal or perennial allergic rhinitis, Drug hypersensitivity reactions, Urticarial transfusion reactions, Acute noninfectious laryngeal edema), Ophthalmic Diseases (Herpes zoster ophthalmicus, Iritis, iridocyclitis, Chorioretinitis, Diffuse posterior uveitis and choroiditis, Optic neuritis), Gastrointestinal Diseases, Fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, Loeffler's syndrome, Aspiration pneumonitis, Hematologic Disorders (Acquired, autoimmune hemolytic anemia, Idiopathic thrombocytopenic purpura in adults, Secondary thrombocytopenia, Erythroblastopenia), Neoplastic Diseases (Leukemias and lymphomas in adults, Acute leukemia of childhood), Edematous States, Acute exacerbations of multiple sclerosis
List of medicines using Hydrocortisone
Tacrolimus 0.1%, 0.03% Topical is indicated for Atopic dermatitis, Allergic contact dermatitis, Severe eczema, Psoriasis, Alopecia areata, Pyoderma gangrenosum, Cutaneous lupus erythematosus, Dermatomyositis, Seborrheic dermatitis, Rosacea, Lichen Planus, Pemphigus Vulgaris, Vitiligo, Graft-Versus-Host Disease, Ichthyosis.
List of medicines using Tacrolimus 0.1%, 0.03% Topical
Tacrolimus 0.1%, 0.03% Topical is indicated for Atopic dermatitis, Allergic contact dermatitis, Severe eczema, Psoriasis, Alopecia areata, Pyoderma gangrenosum, Cutaneous lupus erythematosus, Dermatomyositis, Seborrheic dermatitis, Rosacea, Lichen Planus, Pemphigus Vulgaris, Vitiligo, Graft-Versus-Host Disease, Ichthyosis.
List of medicines using Tacrolimus 0.1%, 0.03% Topical
Tacrolimus 0.1%, 0.03% Topical is indicated for Atopic dermatitis, Allergic contact dermatitis, Severe eczema, Psoriasis, Alopecia areata, Pyoderma gangrenosum, Cutaneous lupus erythematosus, Dermatomyositis, Seborrheic dermatitis, Rosacea, Lichen Planus, Pemphigus Vulgaris, Vitiligo, Graft-Versus-Host Disease, Ichthyosis.
List of medicines using Tacrolimus 0.1%, 0.03% Topical
Cyclosporine is indicated for Ulcerative colitis, Rheumatoid arthritis, Psoriasis, Missed abortion, Nephrotic syndrome , Urticaria, Bone marrow transplantation, Organ transplantation, atopic dermatitis
List of medicines using Cyclosporine
Tacrolimus 0.1%, 0.03% Topical is indicated for Atopic dermatitis, Allergic contact dermatitis, Severe eczema, Psoriasis, Alopecia areata, Pyoderma gangrenosum, Cutaneous lupus erythematosus, Dermatomyositis, Seborrheic dermatitis, Rosacea, Lichen Planus, Pemphigus Vulgaris, Vitiligo, Graft-Versus-Host Disease, Ichthyosis.
List of medicines using Tacrolimus 0.1%, 0.03% Topical
Tacrolimus 0.1%, 0.03% Topical is indicated for Atopic dermatitis, Allergic contact dermatitis, Severe eczema, Psoriasis, Alopecia areata, Pyoderma gangrenosum, Cutaneous lupus erythematosus, Dermatomyositis, Seborrheic dermatitis, Rosacea, Lichen Planus, Pemphigus Vulgaris, Vitiligo, Graft-Versus-Host Disease, Ichthyosis.
List of medicines using Tacrolimus 0.1%, 0.03% Topical
Tacrolimus 0.1%, 0.03% Topical is indicated for Atopic dermatitis, Allergic contact dermatitis, Severe eczema, Psoriasis, Alopecia areata, Pyoderma gangrenosum, Cutaneous lupus erythematosus, Dermatomyositis, Seborrheic dermatitis, Rosacea, Lichen Planus, Pemphigus Vulgaris, Vitiligo, Graft-Versus-Host Disease, Ichthyosis.
List of medicines using Tacrolimus 0.1%, 0.03% Topical
Tacrolimus 0.1%, 0.03% Topical is indicated for Atopic dermatitis, Allergic contact dermatitis, Severe eczema, Psoriasis, Alopecia areata, Pyoderma gangrenosum, Cutaneous lupus erythematosus, Dermatomyositis, Seborrheic dermatitis, Rosacea, Lichen Planus, Pemphigus Vulgaris, Vitiligo, Graft-Versus-Host Disease, Ichthyosis.
List of medicines using Tacrolimus 0.1%, 0.03% Topical
Tacrolimus 0.1%, 0.03% Topical is indicated for Atopic dermatitis, Allergic contact dermatitis, Severe eczema, Psoriasis, Alopecia areata, Pyoderma gangrenosum, Cutaneous lupus erythematosus, Dermatomyositis, Seborrheic dermatitis, Rosacea, Lichen Planus, Pemphigus Vulgaris, Vitiligo, Graft-Versus-Host Disease, Ichthyosis.
List of medicines using Tacrolimus 0.1%, 0.03% Topical
Tacrolimus 0.1%, 0.03% Topical is indicated for Atopic dermatitis, Allergic contact dermatitis, Severe eczema, Psoriasis, Alopecia areata, Pyoderma gangrenosum, Cutaneous lupus erythematosus, Dermatomyositis, Seborrheic dermatitis, Rosacea, Lichen Planus, Pemphigus Vulgaris, Vitiligo, Graft-Versus-Host Disease, Ichthyosis.
List of medicines using Tacrolimus 0.1%, 0.03% Topical
Tacrolimus 0.1%, 0.03% Topical is indicated for Atopic dermatitis, Allergic contact dermatitis, Severe eczema, Psoriasis, Alopecia areata, Pyoderma gangrenosum, Cutaneous lupus erythematosus, Dermatomyositis, Seborrheic dermatitis, Rosacea, Lichen Planus, Pemphigus Vulgaris, Vitiligo, Graft-Versus-Host Disease, Ichthyosis.
List of medicines using Tacrolimus 0.1%, 0.03% Topical
Tacrolimus 0.1%, 0.03% Topical is indicated for Atopic dermatitis, Allergic contact dermatitis, Severe eczema, Psoriasis, Alopecia areata, Pyoderma gangrenosum, Cutaneous lupus erythematosus, Dermatomyositis, Seborrheic dermatitis, Rosacea, Lichen Planus, Pemphigus Vulgaris, Vitiligo, Graft-Versus-Host Disease, Ichthyosis.
List of medicines using Tacrolimus 0.1%, 0.03% Topical
Tacrolimus 0.1%, 0.03% Topical is indicated for Atopic dermatitis, Allergic contact dermatitis, Severe eczema, Psoriasis, Alopecia areata, Pyoderma gangrenosum, Cutaneous lupus erythematosus, Dermatomyositis, Seborrheic dermatitis, Rosacea, Lichen Planus, Pemphigus Vulgaris, Vitiligo, Graft-Versus-Host Disease, Ichthyosis.
List of medicines using Tacrolimus 0.1%, 0.03% Topical
Tacrolimus 0.1%, 0.03% Topical is indicated for Atopic dermatitis, Allergic contact dermatitis, Severe eczema, Psoriasis, Alopecia areata, Pyoderma gangrenosum, Cutaneous lupus erythematosus, Dermatomyositis, Seborrheic dermatitis, Rosacea, Lichen Planus, Pemphigus Vulgaris, Vitiligo, Graft-Versus-Host Disease, Ichthyosis.
List of medicines using Tacrolimus 0.1%, 0.03% Topical
Tacrolimus 0.1%, 0.03% Topical is indicated for Atopic dermatitis, Allergic contact dermatitis, Severe eczema, Psoriasis, Alopecia areata, Pyoderma gangrenosum, Cutaneous lupus erythematosus, Dermatomyositis, Seborrheic dermatitis, Rosacea, Lichen Planus, Pemphigus Vulgaris, Vitiligo, Graft-Versus-Host Disease, Ichthyosis.
List of medicines using Tacrolimus 0.1%, 0.03% Topical
Tacrolimus 0.1%, 0.03% Topical is indicated for Atopic dermatitis, Allergic contact dermatitis, Severe eczema, Psoriasis, Alopecia areata, Pyoderma gangrenosum, Cutaneous lupus erythematosus, Dermatomyositis, Seborrheic dermatitis, Rosacea, Lichen Planus, Pemphigus Vulgaris, Vitiligo, Graft-Versus-Host Disease, Ichthyosis.
List of medicines using Tacrolimus 0.1%, 0.03% Topical